CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market
Holding CGON?
Track your performance easily

CG Oncology, Inc. (CGON) Technical Analysis

78 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
0Bearish
CG Oncology, Inc.’s (CGON) Moving Averages Convergence Divergence (MACD) indicator is 0.77, suggesting CG Oncology, Inc. is a Sell.
CG Oncology, Inc.’s (CGON) 20-Day exponential moving average is 34.47, while CG Oncology, Inc.’s (CGON) share price is $37.02, making it a Buy.
CG Oncology, Inc.’s (CGON) 50-Day exponential moving average is 34.04, while CG Oncology, Inc.’s (CGON) share price is $37.02, making it a Buy.

CG Oncology, Inc. (CGON) Pivot Points

Aug 24, 2024, 11:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.01
34.81
35.37
36.17
36.73
37.53
38.09
Fibonacci
34.81
35.33
35.65
36.17
36.69
37.01
37.53
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CG Oncology, Inc. (CGON) Moving Averages

Aug 24, 2024, 11:14 PM
Period
Simple
Exponential
MA5
36.21Buy
36.07Buy
MA10
34.93Buy
35.25Buy
MA20
33.63Buy
34.47Buy
MA50
33.49Buy
34.04Buy
MA100
34.18Buy
35.25Buy
CG Oncology, Inc.’s (CGON) 10-Day exponential moving average is 35.25, while CG Oncology, Inc.’s (CGON) share price is $37.02, making it a Buy.
CG Oncology, Inc.’s (CGON) 100-Day exponential moving average is 35.25, while CG Oncology, Inc.’s (CGON) share price is $37.02, making it a Buy.
CG Oncology, Inc.’s (CGON) stock price is $37.02 and CG Oncology, Inc.’s (CGON) 50-day simple moving average is 33.49, creating a Buy signal.
CG Oncology, Inc.’s (CGON) stock price is $37.02 and CG Oncology, Inc.’s (CGON) 100-day simple moving average is 34.18, creating a Buy signal.

CG Oncology, Inc. (CGON) Technical Indicators

Aug 24, 2024, 11:14 PM
Name
Value
Implied Action
RSI (14)
61.30
Neutral
STOCH (9,6)
80.74
Sell
STOCHRSI (14)
87.41
Sell
MACD (12,26)
0.77
Sell
ADX (14)
15.40
Buy
Williams %R
-9.44
Sell
CCI (14)
155.21
Sell
ATR (14)
1.93
-
Ultimate Oscillator
57.82
Neutral
ROC
19.38
Buy
CG Oncology, Inc.’s (CGON) Relative Strength Index (RSI) is 61.30, creating a Neutral signal.
CG Oncology, Inc.’s (CGON) Trend Strength Indicator (ADX) is 15.40, creating a Buy signal.
CG Oncology, Inc.’s (CGON) Commodity Channel Index (CCI) is 155.21, creating a Sell signal.
CG Oncology, Inc.’s (CGON) Price Rate of Change (ROC) is 19.38, creating a Buy signal.

FAQ

Is CGON a Buy, Hold, or Sell?
Based on CGON’s technical indicators, CGON is a Buy.
    What is CGON’s RSI (14)?
    CGON’s RSI (14) is 61.30, which suggests CGON is a Neutral.
      What is CGON’s MACD?
      CGON’s MACD is 0.77, which suggests CGON is a Sell.
        What is CGON’s 5-day moving average?
        CGON’s 5-day moving average is 36.21, which suggests CGON is a Buy.
          What is CGON’s 20-day moving average?
          CGON 20-day moving average is 33.63, which suggests CGON is a Buy.
            What is CGON’s 50-day moving average?
            CGON’s 50-day moving average is 33.49, which suggests CGON is a Buy.
              What is CGON’s 200-day moving average?
              Currently, no data Available
              What is CGON’s Williams % R (14)?
              CGON’s Williams % R (14) is -9.44, which suggests CGON is a Sell.
                What is CGON’s CCI (14)?
                CGON’s CCI (14) is 155.21, which suggests CGON is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis